Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomised, Multi-centre, Blind-observer, Controlled, Parallel-group Study Comparing the Efficacy and Safety of DERMAGEN® Versus Conventional Treatment in the Treatment of Diabetic Neuropathic Foot Ulcer

NCT00521937 is registered in ClinicalTrials.gov with Laboratoires Genévrier as lead sponsor.

NCT NCT00521937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00521937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomised, Multi-centre, Blind-observer, Controlled, Parallel-group Study Comparing the Efficacy and Safety of DERMAGEN® Versus Conventional Treatment in the Treatment of Diabetic Neuropathic Foot Ulcer
Lead sponsor
Laboratoires Genévrier
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2009
Completion date
December 31, 2010
Enrollment
388 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, foot ulcer